Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Oruka Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ORKA
Nasdaq
2836
orukatx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Oruka Therapeutics, Inc.
Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says
- Sep 24th, 2026 11:02 am
ORKA Stock Down 5% Despite Positive Week 28 Psoriasis Efficacy Data
- Sep 24th, 2026 7:35 am
What Oruka Therapeutics (ORKA)'s Phase 2a Psoriasis Data Means For Shareholders
- Sep 23rd, 2026 6:16 pm
The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data
- Sep 23rd, 2026 2:12 pm
Oruka Therapeutics Says Psoriasis Drug Shows Deepening Efficacy
- Sep 23rd, 2026 7:49 am
Oruka Therapeutics Shares Fall 5% After Week 28 ORKA-001 Trial Data
- Sep 23rd, 2026 6:52 am
Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing
- Sep 23rd, 2026 5:00 am
Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference
- Sep 9th, 2026 2:01 pm
ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know
- Aug 28th, 2026 9:10 am
Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer
- Aug 24th, 2026 2:01 pm
4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026
- Aug 11th, 2026 7:44 am
HMI Capital Pares Its Stake in AI Company nCino
- Jul 10th, 2026 5:26 pm
H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News
- Jul 1st, 2026 3:23 pm
Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean
- Jun 27th, 2026 1:48 pm
Oruka Therapeutics' Head of Finance Sold Over 10,000 Company Shares. What Does That Mean for Investors?
- Jun 24th, 2026 3:44 pm
Oruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock?
- Jun 12th, 2026 10:00 am
Wall Street Analysts Believe Oruka Therapeutics, Inc. (ORKA) Could Rally 111.13%: Here's is How to Trade
- Jun 10th, 2026 7:55 am
An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million
- May 31st, 2026 8:41 am
Scroll